MedStar Health News

A small phase I study provides molecular evidence that an FDA-approved drug for leukemia significantly increased brain dopamine and reduced toxic proteins linked to disease progression in patients with Parkinson’s disease or dementia with Lewy bodies.

The first clinical trial to compare standard of care chemotherapy with molecularly tailored therapy (also known as precision medicine) for metastatic pancreatic cancer is now enrolling patients at Georgetown Lombardi Comprehensive Cancer Center.

Back in November 2015 Koepnick of Annandale, Virginia was feeling run down and had a persistent cough. A trip the emergency room and a series of tests revealed his leukemia.

In 2013 at the age of 53, Semple, a healthy trialthlete, was diagnosed with advanced cancer of the thymus, a small gland in the neck that produces T cells for the immune system.

MedStar Georgetown’s Michael Atkins, MD, translated his vast knowledge of cancer immunology into a classroom-style lecture Monday for a standing-room only Congressional briefing. Atkins and five other elite leaders in oncology research, advocacy and industry aimed to educate members of Congress and their staffs about various aspects of cancer.

Neal Bobys became the 1000th prostate cancer patient to be treated with CyberKnife at MedStar Georgetown.